Is there a relationship between hepatitis C virus infection and antiretroviral-associated lipoatrophy?
Zylberberg
H
H
Nalpas
B
B
Pol
S
S
Bréchot
C
C
Viard
J P
JP
D019380:Anti-HIV Agents / Q000009:adverse effects*; D015658:HIV Infections / Q000150:complications* / Q000821:virology; D015497:HIV-1; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D008060:Lipodystrophy / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors